Disseminated Virus Infection Research Articles

Mice with FVB-derived sequence on chromosome 17 succumb to disseminated virus infection due to aberrant NK cell and T cell responses

Zoonotic arenavirus infections can result in viral hemorrhagic disease, characterized by platelet loss, petechia, and multi-organ injury. The mechanisms governing these outcomes are likely impacted by virus strain and infection dose, as well as an individual's genetic background and immune constitution. To better understand the processes leading to severe pathogenesis, we compared two strains of inbred mice, C57BL/6J (B6) and FVB/NJ (FVB), that have diametrically opposed outcomes during disseminated lymphocytic choriomeningitis virus (LCMV) infection. Infection caused minimal pathogenesis in B6 mice, whereas FVB mice developed acute hepatitis and perished due, in part, to aberrant NK cell and Tcell responses. Susceptible mice showed an outgrowth of cytolytic CD4+ Tcells and loss of Treg cells. B6 congenic mice with the FVB allele at a 25Mb locus on chromosome 17 recapitulated FVB pathogenesis upon infection. A locus containing a limited number of variants in immune-related genes greatly impacts survival during infection.

Targeted surveillance reveals native and invasive mosquito species infected with Usutu virus

BackgroundThe emergence of Usutu virus (USUV) in Europe was first reported in Austria, 2001, and the virus has since spread to many European countries. Initial outbreaks are marked by a mass die-off of European blackbirds (Turdus merula) and other bird species. During outbreaks, the virus has been detected in pools of Culex pipiens mosquitoes, and these mosquitoes are probably the most important enzootic vectors. Beginning in 2017, a second wave of blackbird deaths associated with USUV was observed in eastern Austria; the affected areas expanded to the Austrian federal states of Styria in the south and to Upper Austria in the west in 2018. We sampled the potential vector population at selected sites of bird deaths in 2018 in order to identify infected mosquitoes.ResultsWe detected USUV RNA in 16 out of 19 pools of Cx. pipiens/Cx. torrentium mosquitoes at sites of USUV-linked blackbird mortality in Linz and Graz, Austria. A disseminated virus infection was detected in individuals from selected pools, suggesting that Cx. pipiens form pipiens was the principal vector. In addition to a high rate of infected Cx. pipiens collected from Graz, a disseminated virus infection was detected in a pool of Aedes japonicus japonicus.ConclusionsWe show herein that naturally-infected mosquitoes at foci of USUV activity are primarily Cx. pipiens form pipiens. In addition, we report the first natural infection of Ae. j. japonicus with USUV, suggesting that it may be involved in the epizootic transmission of USUV in Europe. Ae. j. japonicus is an invasive mosquito whose range is expanding in Europe.

Immune response-related genes associated to blocking midgut dengue virus infection in Aedes aegypti strains that differ in susceptibility.

Aedes (Stegomyia) aegypti, the principal global vector of dengue viruses, has differences in its susceptibility to dengue virus infection. We compared the global expression of genes in the midguts of Colombian Ae. aegypti dengue-susceptible (Cali-S) and dengue-refractory (Cali-MIB) field derived strains after ingesting either a sugarmeal, a bloodmeal, or a bloodmeal containing dengue virus serotype 2 (DENV-2). Microarray-based transcriptome analysis among treatments indicated a total of 4725 transcripts with differential expression between the two strains. Eleven genes were selected from different functional groups based on their significant up or down expression levels as well as reports in the literature suggesting they are associated with dengue virus elimination. We measured mRNA abundance of these 11 genes at 0, 8, 24, and 36 h postinfection using quantitative real time PCR (qPCR) to confirm the microarray results and assess any temporal patterns. Four genes were selected (Gram-negative binding protein-GNBP [AAEL009176], Niemann Pick Type-C2-NPC2 [AAEL015136], Keratinocyte lectin [AAEL009842], and Cathepsin-b [AAEL007585]) for knockdown experiments using RNA interference (RNAi) methodology to determine the phenotype (DENV-2 susceptible or refractory). Silencing GNBP, Cathepsin-b and Keratinocyte lectin reduced the percentage of mosquitoes with disseminated virus in the Cali-S strain to 8%, 20%, and 12% respectively compared with 96% in the controls. Silencing of NPC2 increased the percentage of mosquitos with disseminated virus infections in Cali-MIB to 66% compared with 35% in the controls. This study provides insight into genes that may contribute to the Cali-S susceptible and Cali-MIB refractory phenotypes in Ae. aegypti.

The Transcription Factor IRF3 Triggers “Defensive Suicide” Necrosis in Response to Viral and Bacterial Pathogens

Although molecular components that execute noninflammatory apoptotic cell death are well defined, molecular pathways that trigger necrotic cell death remain poorly characterized. Here, we show that in response to infection with adenovirus or Listeria monocytogenes, macrophages invivo undergo rapid proinflammatory necrotic death that is controlled by interferon-regulatory factor 3 (IRF3). The transcriptional activity of IRF3 is, surprisingly, not required for the induction of necrosis, and it proceeds normally in mice deficient in all known regulators of necrotic death or IRF3 activation, including RIPK3, caspases 1, 8, or 11, STING, and IPS1/MAVS. Although L. monocytogenes triggers necrosis to promote the infection, IRF3-dependent necrosis is required for reducing pathogen burden in the models of disseminated infection with adenovirus. Therefore, our studies implicate IRF3 as a principal and nonredundant component of a physiologically regulated necrotic cell-death pathway that operates as an effective innate immune mechanism of host protection against disseminated virus infection.

Memory B Cells Protect from CMV Infection in the Absence of T Cells.

Infections with cytomegalovirus are still a major clinical problem in immunosuppressed patients e.g. after bone marrow or stem cell transplantation. To prevent clinical overt disease resulting from disseminated virus infection, immunoprophylaxis and/or -therapy are considered a major goal. The humoral immune response contributes to immune protection against CMV by providing neutralizing antibodies. However, in the early phase after transplantation a primary immune response is not possible. Humoral anti-CMV immune effector functions can only be provided by memory B cells. The activation requirements for resting memory B cells are unclear. Using non-infectious hCMV particles in mice we have recently shown that activation of virus-specific memory B cells to secrete IgG is independent of cognate or bystander T cell help. To analyze whether transfer of memory B cells into immunodeficient mice can protect from lethal infection we switched to an infectious animal model using mCMV. When memory B cells from mCMV-infected mice were adoptively transferred into RAG-1−/− mice, a strong IgG anti-mCMV titer developed within 4–6 days after infection with mCMV. Virus dissemination and subsequent disease was inhibited. A 100–1000 fold decrease of virus titers and a 1.000–10.000 fold decrease of viral DNA load in spleen and lung was observed in mice that received mCMV specific memory B cells. Even in an established mCMV infection virus dissemination and subsequent disease could be prevented by means of adoptive memory B cell transfer. In further experiments we also used a virus mutant that cannot be controlled by NK cells in C57Bl/6 mice. Even in this experimental system we could demonstrate that adoptive transfer of memory B cells in the absence CD4 and CD8 cells is sufficient to protect from viral dissemination and rapid lethality. Our results show that memory B cells can mediate protection against mCMV in the absence of cognate or bystander T cell help. Similar regimens might be a therapeutic option for CMV reactivation after bone marrow transplantation in patients.

Cyclic HPMPC is safe and effective against systemic guinea pig cytomegalovirus infection in immune compromised animals

Cidofovir (HPMPC) is licensed for the treatment of cytomegalovirus (CMV) retinitis in patients with AIDS but its use is limited by nephrotoxicity. We evaluated the safety and efficacy of 1-[((s)-2-hydroxy-2-oxo-1,4,2-dioxaphosphorinan-5-yl)methyl]cytosine dihydrate (CHPMPC) the cyclic congener of cidofovir. Treatment was well tolerated both in normal guinea pigs and in animals immune compromised with cyclophosphamide. Further, blood chemistry analysis showed no adverse effects of CHPMPC treatment on kidney or liver function. In efficacy studies in immune compromised guinea pigs challenged with a virulent salivary gland passaged guinea pig CMV, CHPMPC treatment significantly reduced mortality resulting from disseminated virus infection. Quantitative culture showed that treatment also significantly reduced virus replication in the liver and spleen, but not the lungs of infected animals. The efficacy of CHPMPC combined with its improved safety profile appear to make it an attractive alternative to cidofovir for the treatment of herpesvirus infections. Further evaluation is warranted.

Determinants of the ability of malignant fibroma virus to induce immune dysfunction and tumor dissemination in vivo

The relationship of virus-induced immunological dysfunction and tumor dissemination was studied using two related tumor-causing leporipoxviruses: malignant fibroma virus (MV) and Shope fibroma virus (SFV). Recombinant viruses, produced by transferring MV's 10.7 kb BamHI C fragment to SFV, replicate in lymphocytes and suppress lymphocyte function in vitro. Those recombinants that replicate in lymphocytes and suppress lymphocyte function in vitro share about 3.5 kb from MV's C fragment. Some recombinants mimic MV in producing immune suppression and disseminated virus infection in vivo. Other recombinants, even some that are highly immunosuppressive in vitro (e.g. R71), only variably induce immune suppression in vivo, and do not cause disseminated disease. A segment of DNA from MV that transfers to Shope fibroma virus almost all of MV's virulence in vivo was identified.